James A Kaye

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Topics

Cross Sectional

Multiple Myeloma

Acute Lymphoblastic Leukemia

Top Venues

Prostate cancer

Pharmacoepidemiology and drug safety

Future oncology (London, England)

ClinicoEconomics and outcomes research : CEOR

This page only lists publications with an associated author ORCID identifier.

Publications

Djeneba Audrey Djibo, Andrea V Margulis, Cheryl N McMahill-Walraven, Catherine W Saltus, Patricia Shuminski, James A Kaye, Catherine B Johannes, Mark Libertin, Shelli Graham
Validation of an ICD-10 case-finding algorithm for endometrial cancer in US insurance claims. Pharmacoepidemiology and drug safety (2023)
Catherine B Johannes, Catherine W Saltus, James A Kaye, Brian Calingaert, Sigal Kaplan, Mark Forrest Gordon, Elizabeth B Andrews
The risk of melanoma with rasagiline compared with other antiparkinsonian medications: A retrospective cohort study in the United States medicare database. Pharmacoepidemiology and drug safety 31 (6) (2022)
Alejandro Arana, Jesper Hallas, Josephina G Kuiper, Helen Booth, Johan Reutfors, Brian Calingaert, Lars Christian Lund, Elizabeth Crellin, Marcus Schmitt-Egenolf, James A Kaye, Karin Gembert, Kenneth J Rothman, Helle Kieler, Daniel Dedman, Eline Houben, Lia Gutiérrez, Nina Sahlertz Kristiansen, Susanna Perez-Gutthann
Long-Term Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus and Pimecrolimus: Final Results from the Extension of the Cohort Study Protopic Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (JOELLE). Clinical epidemiology 13 (2021)
Marco Boeri, Anna G Purdum, Jessie Sutphin, A Brett Hauber, James A Kaye
CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma: physician preferences trading off benefits, risks and time to infusion. Future oncology (London, England) 17 (34) (2021)
Jan Bassali, Ian Gopal Gould, James A Kaye, Deirdre Mladsi, Jyotsna Mehta
US Budget Impact Model for Selinexor in Relapsed or Refractory Multiple Myeloma. ClinicoEconomics and outcomes research : CEOR 12 (2020)
Catherine W Saltus, Zdravko P Vassilev, Jihong Zong, Brian Calingaert, Elizabeth B Andrews, Montse Soriano-Gabarró, James A Kaye
Incidence of Second Primary Malignancies in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the United States. Prostate cancer 2019 (2019)
Catherine W Saltus, Zdravko P Vassilev, Jihong Zong, Brian Calingaert, Elizabeth B Andrews, Montse Soriano-Gabarró, James A Kaye
Corrigendum to "Incidence of Second Primary Malignancies in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the United States". Prostate cancer 2019 (2019)
Alison Tse Kawai, David Martinez, Catherine W Saltus, Zdravko P Vassilev, Montse Soriano-Gabarró, James A Kaye
Incidence of Skeletal-Related Events in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US. Prostate cancer 2019 (2019)